End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.92 CNY | +0.07% |
|
-0.53% | -6.81% |
07-11 | Yiling Pharmaceutical Receives Regulatory Greenlight for Review of Banxia Baizhu Tianma Granules | MT |
07-08 | Yiling Pharmaceutical Gets Nod to Trial G201-Na Capsule | MT |
Business description: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Number of employees: 11,708
Sales by Activity: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Pharmaceutical Manufacturing | 8.78B | 10.12B | 12.53B | 10.32B | 6.51B |
Geographical breakdown of sales: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
China | 8.48B | 9.76B | 12.07B | 10.08B | 6.22B |
Foreign | 304M | 357M | 463M | 239M | 295M |
Executive Committee: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Manager | Title | Age | Since |
---|---|---|---|
Xiang Jun Wu
CEO | Chief Executive Officer | 50 | 2013-03-31 |
Chen Guang Li
DFI | Director of Finance/CFO | 52 | 2018-04-23 |
Qiu Lian Zhang
PRN | Corporate Officer/Principal | 55 | 2020-01-15 |
Rui Wu
SEC | Corporate Secretary | 45 | 2010-08-30 |
Hua Wang
IRC | Investor Relations Contact | - | - |
Composition of the Board of Directors: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Director | Title | Age | Since |
---|---|---|---|
Yi Ling Wu
CHM | Chairman | 76 | 2012-08-30 |
Xiang Jun Wu
BRD | Director/Board Member | 50 | 2010-08-30 |
Chen Guang Li
BRD | Director/Board Member | 52 | 2018-05-16 |
Xue Dong Gao
CHM | Chairman | 55 | 2014-08-18 |
Rui Hua Niu
BRD | Director/Board Member | 46 | 2009-02-28 |
Rui Wu
BRD | Director/Board Member | 45 | 2016-12-11 |
Gen Wu Liu
BRD | Director/Board Member | 52 | 2014-08-17 |
Zhen Wang
BRD | Director/Board Member | 52 | 2016-12-11 |
Qiu Lian Zhang
BRD | Director/Board Member | 55 | 2015-03-15 |
Wei Dong Xu
BRD | Director/Board Member | 57 | 2020-01-15 |
Company details: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
No. 238 Tianshan Avenue High-tech Industrial Dev Zone
050035, Shijiazhuang
+86 311 8590 1712
http://www.yiling.cn
Alternative Medicine
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.07% | -0.53% | -4.48% | -42.94% | 3.48B | ||
+0.60% | -1.19% | -9.23% | +34.66% | 4.53B | ||
-0.08% | +0.69% | -17.57% | +5.34% | 3.37B | ||
-0.25% | -0.50% | +22.87% | +52.26% | 3.3B | ||
+0.73% | +2.28% | +3.01% | +38.94% | 3.12B | ||
+0.42% | +1.56% | +8.83% | -13.21% | 2.49B | ||
+1.67% | -0.68% | +25.58% | +92.35% | 1.82B | ||
-0.26% | -2.64% | -3.94% | +92.44% | 1.8B | ||
-0.25% | +0.25% | +25.95% | -43.63% | 1.67B | ||
+0.09% | -1.23% | +16.18% | -12.98% | 1.66B | ||
Average | +0.27% | +0.39% | +6.72% | +20.32% | 2.72B | |
Weighted average by Cap. | +0.28% | +0.47% | +3.67% | +19.35% |
Sector
Sell
Buy

Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.92CNY
Average target price
15.38CNY
Spread / Average Target
+3.08%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002603 Stock
- Company Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition